pharmaceutical investing Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse
pharmaceutical investing Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results
pharmaceutical investing Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse
Homerun Resources Inc. Signs Binding LOI for the Acquisition of Additional Mineral Rights in the Santa Maria Eterna Silica Sand District